AKBA compared with FLGT: revenue, margins and what each company keeps, and the suppliers and customers both name

AKBAAkebia Therapeutics, Inc.

Mkt capRevenueRevenue

FLGTFulgent Genetics, Inc.

Mkt capRevenueRevenue

Compare

AKBAAkebia Therapeutics, Inc.

FLGTFulgent Genetics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

AKBA, solidFLGT, dashed

Supply-chain overlap

Revenue flow

AKBA: latest quarter is a loss; flow not drawable. FLGT: latest quarter is a loss; flow not drawable.Method ›

AKBAAkebia Therapeutics, Inc.

0.74▲+0.20%· post 0.71

Mkt cap$195.8MRevenue$49MQ2 FY26Revenue$236MFY25

FLGTFulgent Genetics, Inc.

20.59▼−5.04%· post 20.59

ClosedOct 30 '26

Mkt cap$567.4MRevenue$85MQ2 FY26Revenue$323MFY25

Compare

ClosedOct 30 '26

AKBAAkebia Therapeutics, Inc.

FLGTFulgent Genetics, Inc.

0.74▲+0.20%post 0.71

Price

20.59▼−5.04%post 20.59

$195.8M

Mkt cap

$567.4M

Q2 FY26$49M

Revenue

$85MQ2 FY26

FY25$236M

Revenue

$323MFY25

AKBA0.74▲+0.20%vsFLGT20.59▼−5.04%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AKBA 21

CAHCardinal Healthsupplier

DVADaVitacustomer

QTTBQ32 Biosupplier

CYCNCyclerion Therapeuticssupplier

17 more · AKBA chain ›

Shared 0

No shared counterparties.

Only FLGT 4

ABTAbbott Laboratoriessupplier

ILMNIlluminasupplier

—Leica Biosystemsunlistedsupplier

—Roche

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier